Although studies have demonstrated the benefits of using IFN-γ tests in low-incidence countries where a new positive result appears to demonstrate recent infection [24], in middle- to high-incidence countries the high number of positive individuals may make wide scale chemoprophylaxis unworkable. This evidence concerns the gene IFNG and infection.